4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-023367
Sr. VP, New Product Dev. gave up 498 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Kieffer Tara Lynn · Sr. VP, New Product Dev.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-01 | Shares withheld for taxes : show line 1 in the form | −498 | $44.33 | $22,076 | 25,866 | D |
Loading xslF345X03/form4.xml…